Cargando…

Plasma neutrophil gelatinase-associated lipocalin at intensive care unit admission as a predictor of acute kidney injury progression

BACKGROUND: Acute kidney injury (AKI) is a common complication in patients during intensive care unit (ICU) admission. AKI is defined as an increase in serum creatinine (SCr) and/or a reduction in urine output. SCr is a marker of renal function with several limitations, which led to the search for b...

Descripción completa

Detalles Bibliográficos
Autores principales: Koeze, Jacqueline, van der Horst, Iwan C C, Keus, Frederik, Wiersema, Renske, Dieperink, Wim, Kootstra-Ros, Jenny E, Zijlstra, Jan G, van Meurs, Matijs
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769547/
https://www.ncbi.nlm.nih.gov/pubmed/33391742
http://dx.doi.org/10.1093/ckj/sfaa002
_version_ 1783629347690643456
author Koeze, Jacqueline
van der Horst, Iwan C C
Keus, Frederik
Wiersema, Renske
Dieperink, Wim
Kootstra-Ros, Jenny E
Zijlstra, Jan G
van Meurs, Matijs
author_facet Koeze, Jacqueline
van der Horst, Iwan C C
Keus, Frederik
Wiersema, Renske
Dieperink, Wim
Kootstra-Ros, Jenny E
Zijlstra, Jan G
van Meurs, Matijs
author_sort Koeze, Jacqueline
collection PubMed
description BACKGROUND: Acute kidney injury (AKI) is a common complication in patients during intensive care unit (ICU) admission. AKI is defined as an increase in serum creatinine (SCr) and/or a reduction in urine output. SCr is a marker of renal function with several limitations, which led to the search for biomarkers for earlier AKI detection. Our aim was to study the predictive value of plasma neutrophil gelatinase-associated lipocalin (NGAL) at admission as a biomarker for AKI progression during the first 48 h of ICU admission in an unselected, heterogeneous ICU patient population. METHODS: We conducted a prospective observational study in an academic tertiary referral ICU population. We recorded AKI progression in all ICU patients during the first 48 h of ICU admission in a 6-week period. Plasma NGAL was measured at admission but levels were not reported to the attending clinicians. As possible predictors of AKI progression, pre-existing AKI risk factors were recorded. We examined the association of clinical parameters and plasma NGAL levels at ICU admission with the incidence and progression of AKI within the first 48 h of the ICU stay. RESULTS: A total of 361 patients were included. Patients without AKI progression during the first 48 h of ICU admission had median NGAL levels at admission of 115 ng/mL [interquartile range (IQR) 81–201]. Patients with AKI progression during the first 48 h of ICU admission had median NGAL levels at admission of 156 ng/mL (IQR 97–267). To predict AKI progression, a multivariant model with age, sex, diabetes mellitus, body mass index, admission type, Acute Physiology and Chronic Health Evaluation score and SCr at admission had an area under the receiver operating characteristics (ROC) curve of 0.765. Adding NGAL to this model showed a small increase in the area under the ROC curve to 0.783 (95% confidence interval 0.714–0.853). CONCLUSIONS: NGAL levels at admission were higher in patients with progression of AKI during the first 48 h of ICU admission, but adding NGAL levels at admission to a model predicting this AKI progression showed no significant additive value.
format Online
Article
Text
id pubmed-7769547
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-77695472020-12-31 Plasma neutrophil gelatinase-associated lipocalin at intensive care unit admission as a predictor of acute kidney injury progression Koeze, Jacqueline van der Horst, Iwan C C Keus, Frederik Wiersema, Renske Dieperink, Wim Kootstra-Ros, Jenny E Zijlstra, Jan G van Meurs, Matijs Clin Kidney J Original Articles BACKGROUND: Acute kidney injury (AKI) is a common complication in patients during intensive care unit (ICU) admission. AKI is defined as an increase in serum creatinine (SCr) and/or a reduction in urine output. SCr is a marker of renal function with several limitations, which led to the search for biomarkers for earlier AKI detection. Our aim was to study the predictive value of plasma neutrophil gelatinase-associated lipocalin (NGAL) at admission as a biomarker for AKI progression during the first 48 h of ICU admission in an unselected, heterogeneous ICU patient population. METHODS: We conducted a prospective observational study in an academic tertiary referral ICU population. We recorded AKI progression in all ICU patients during the first 48 h of ICU admission in a 6-week period. Plasma NGAL was measured at admission but levels were not reported to the attending clinicians. As possible predictors of AKI progression, pre-existing AKI risk factors were recorded. We examined the association of clinical parameters and plasma NGAL levels at ICU admission with the incidence and progression of AKI within the first 48 h of the ICU stay. RESULTS: A total of 361 patients were included. Patients without AKI progression during the first 48 h of ICU admission had median NGAL levels at admission of 115 ng/mL [interquartile range (IQR) 81–201]. Patients with AKI progression during the first 48 h of ICU admission had median NGAL levels at admission of 156 ng/mL (IQR 97–267). To predict AKI progression, a multivariant model with age, sex, diabetes mellitus, body mass index, admission type, Acute Physiology and Chronic Health Evaluation score and SCr at admission had an area under the receiver operating characteristics (ROC) curve of 0.765. Adding NGAL to this model showed a small increase in the area under the ROC curve to 0.783 (95% confidence interval 0.714–0.853). CONCLUSIONS: NGAL levels at admission were higher in patients with progression of AKI during the first 48 h of ICU admission, but adding NGAL levels at admission to a model predicting this AKI progression showed no significant additive value. Oxford University Press 2020-02-17 /pmc/articles/PMC7769547/ /pubmed/33391742 http://dx.doi.org/10.1093/ckj/sfaa002 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of ERA-EDTA. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Original Articles
Koeze, Jacqueline
van der Horst, Iwan C C
Keus, Frederik
Wiersema, Renske
Dieperink, Wim
Kootstra-Ros, Jenny E
Zijlstra, Jan G
van Meurs, Matijs
Plasma neutrophil gelatinase-associated lipocalin at intensive care unit admission as a predictor of acute kidney injury progression
title Plasma neutrophil gelatinase-associated lipocalin at intensive care unit admission as a predictor of acute kidney injury progression
title_full Plasma neutrophil gelatinase-associated lipocalin at intensive care unit admission as a predictor of acute kidney injury progression
title_fullStr Plasma neutrophil gelatinase-associated lipocalin at intensive care unit admission as a predictor of acute kidney injury progression
title_full_unstemmed Plasma neutrophil gelatinase-associated lipocalin at intensive care unit admission as a predictor of acute kidney injury progression
title_short Plasma neutrophil gelatinase-associated lipocalin at intensive care unit admission as a predictor of acute kidney injury progression
title_sort plasma neutrophil gelatinase-associated lipocalin at intensive care unit admission as a predictor of acute kidney injury progression
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769547/
https://www.ncbi.nlm.nih.gov/pubmed/33391742
http://dx.doi.org/10.1093/ckj/sfaa002
work_keys_str_mv AT koezejacqueline plasmaneutrophilgelatinaseassociatedlipocalinatintensivecareunitadmissionasapredictorofacutekidneyinjuryprogression
AT vanderhorstiwancc plasmaneutrophilgelatinaseassociatedlipocalinatintensivecareunitadmissionasapredictorofacutekidneyinjuryprogression
AT keusfrederik plasmaneutrophilgelatinaseassociatedlipocalinatintensivecareunitadmissionasapredictorofacutekidneyinjuryprogression
AT wiersemarenske plasmaneutrophilgelatinaseassociatedlipocalinatintensivecareunitadmissionasapredictorofacutekidneyinjuryprogression
AT dieperinkwim plasmaneutrophilgelatinaseassociatedlipocalinatintensivecareunitadmissionasapredictorofacutekidneyinjuryprogression
AT kootstrarosjennye plasmaneutrophilgelatinaseassociatedlipocalinatintensivecareunitadmissionasapredictorofacutekidneyinjuryprogression
AT zijlstrajang plasmaneutrophilgelatinaseassociatedlipocalinatintensivecareunitadmissionasapredictorofacutekidneyinjuryprogression
AT vanmeursmatijs plasmaneutrophilgelatinaseassociatedlipocalinatintensivecareunitadmissionasapredictorofacutekidneyinjuryprogression